12th Annual New York Lung Cancer Symposium
In-Person Event
Nov 11, 2017
New York, New York, USASpeakers
OVERVIEW
12th Annual New York Lung Cancer Symposium is organized by Physicians Education Resource, LLC (PER) and will be held on Nov 11, 2017 at New York Marriott Marquis, New York, United States of America.
Target Audience :
This educational activity is directed toward medical oncologists, radiation oncologists, thoracic surgeons, pulmonologists involved in the treatment and management of patients with lung cancer. Fellows, nurse practitioners, nurses, physician assistants, pharmacists, researchers, and other health care professionals interested in the treatment of lung cancer may also participate. This CME Conference has been approved for a maximum of 22.00 AMA PRA Category 1 Credits.
Course Overview :
The 12th Annual New York Lung Cancers Symposium is a 1-day educational and scientific meeting that will provide an update on state-of-the-art management of patients with lung cancer, as well as a focus on future therapies in development.
The past decade in lung cancer research has yielded a wealth of therapeutic options for patients with lung cancer, as well as greater knowledge of the many different subtypes of this disease. In particular, agents targeting oncogenic drivers and immunotherapeutic approaches have transformed the management of patients with lung cancer in recent years. Furthermore, numerous investigational approaches are in late-phase evaluation, with the potential to change standards of care in 2016, and beyond. However, although these developments hold the promise to further improve outcomes for patients with lung cancer, they also raise challenges for busy clinicians to maintain state-of-the-art approaches in their practices.
Additional details will be posted as soon as they are available.
Target Audience :
This educational activity is directed toward medical oncologists, radiation oncologists, thoracic surgeons, pulmonologists involved in the treatment and management of patients with lung cancer. Fellows, nurse practitioners, nurses, physician assistants, pharmacists, researchers, and other health care professionals interested in the treatment of lung cancer may also participate. This CME Conference has been approved for a maximum of 22.00 AMA PRA Category 1 Credits.
Course Overview :
The 12th Annual New York Lung Cancers Symposium is a 1-day educational and scientific meeting that will provide an update on state-of-the-art management of patients with lung cancer, as well as a focus on future therapies in development.
The past decade in lung cancer research has yielded a wealth of therapeutic options for patients with lung cancer, as well as greater knowledge of the many different subtypes of this disease. In particular, agents targeting oncogenic drivers and immunotherapeutic approaches have transformed the management of patients with lung cancer in recent years. Furthermore, numerous investigational approaches are in late-phase evaluation, with the potential to change standards of care in 2016, and beyond. However, although these developments hold the promise to further improve outcomes for patients with lung cancer, they also raise challenges for busy clinicians to maintain state-of-the-art approaches in their practices.
Additional details will be posted as soon as they are available.
KEY DATES
11 Nov, 2017
Event Start Date
11 Nov, 2017
Event End Date
SPECIALITIES
OncologyPulmonary MedicineSUGGESTED HOTELS
CONFERENCE VENUE
Crowne Plaza Hotel, Times SquareRELATED CONFERENCES & LIVE WEBINARS
Quick Links